journal cover

Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions

Pancreas

Jul 31, 2008

M AdhamChristian Partensky

Download from

Publisher
PubMed

Abstract

Long-term survival after pancreatectomy for pancreatic duct adenocarcinoma has been rarely reported. Factors influencing survival are still debated. The aim of the study is to report a French multicentric series of long-term survivors after pancreatectomy for pancreatic duct adenocarcin...read more

Mentioned in this Paper

Immunologic Adjuvants
Pancreatic Ductal Adenocarcinoma
Entire Portal Vein
Kaplan-Meier Estimate
Adjuvant
Entire Trunk of Portal Vein
Pancreaticoduodenectomy
Mixed Salivary Gland Tumor
Portal Vein Structure
Neoplasms
Paper Details
References
  • References44
  • Citations37
12345
  • References44
  • Citations37
1234

Feeds With Similar Papers

Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma holds a significant mortality risk, largely due to its late diagnosis and ineffective chemotherapeutic response. This gastrointestinal malignancy offers a poor prognosis and the only potential cure is through surgical resection. Here are the latest discoveries pertaining to this disease.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Radiosensitizers

A radiosensitizer is an agent that makes tumor cells more sensitive to radiation therapy. It is sometimes also known as a radiation sensitizer or radio-enhancer. Discover the latest research on radiosensitizers here.

Related Papers

The British Journal of Surgery

Current standards of surgery for pancreatic cancer(opens in new tab)

The British Journal of SurgeryOctober 23, 2004
N AlexakisJohn P Neoptolemos
© 2020 Meta ULC. All rights reserved

Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions

Pancreas

Jul 31, 2008

M AdhamChristian Partensky

PMID: 18665012

DOI: 10.1097/mpa.0b013e31818166d2

Abstract

Long-term survival after pancreatectomy for pancreatic duct adenocarcinoma has been rarely reported. Factors influencing survival are still debated. The aim of the study is to report a French multicentric series of long-term survivors after pancreatectomy for pancreatic duct adenocarcin...read more

Mentioned in this Paper

Immunologic Adjuvants
Pancreatic Ductal Adenocarcinoma
Entire Portal Vein
Kaplan-Meier Estimate
Adjuvant
Entire Trunk of Portal Vein
Pancreaticoduodenectomy
Mixed Salivary Gland Tumor
Portal Vein Structure
Neoplasms

Feeds With Similar Papers

Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma holds a significant mortality risk, largely due to its late diagnosis and ineffective chemotherapeutic response. This gastrointestinal malignancy offers a poor prognosis and the only potential cure is through surgical resection. Here are the latest discoveries pertaining to this disease.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Related Papers

The British Journal of Surgery

Current standards of surgery for pancreatic cancer(opens in new tab)

The British Journal of SurgeryOctober 23, 2004
N AlexakisJohn P Neoptolemos
Paper Details
References
  • References44
  • Citations37
12345
  • References44
  • Citations37
1234

Download from

Publisher
PubMed
/papers/long-term-survival-5-20-years-after/18665012